Sepsis is a complex, life-threatening hyperinflammatory syndrome associated with organ failure and high mortality due to lack of effective treatment options. Here we report a core-shell hydrogel nanoparticle with the core functionalized with telodendrimer (TD) nanotrap (NT) to control hyperinflammation in sepsis. The combination of multi-valent charged and hydrophobic moieties in TD enables effective binding with biomolecules in NT. The higher crosslinking in the shell structure of nanogel excludes the abundant large serum proteins and allows for size-selectivity in scavenging the medium-sized septic molecules (10-30 kDa), e.g., lipopolysaccharides (LPS, a potent endotoxin in sepsis), thus reducing cytokine production. At the same time, the core-shell TD NT nanogel captures the over-flowing proinflammatory cytokines effectively both in vitro and in vivo from biological fluids to further control hyperinflammation. Intraperitoneal injection of core-shell TD NT nanogel effectively attenuates NF-κB activation and cytokine production in LPS-induced septic mouse models. These results indicate the potential applications of the injectable TD NT core-shell nanogel to attenuate local or systemic inflammation.
Keyphrases
- acute kidney injury
- lps induced
- septic shock
- inflammatory response
- intensive care unit
- quantum dots
- signaling pathway
- mouse model
- anti inflammatory
- drug delivery
- oxidative stress
- hyaluronic acid
- stem cells
- cardiovascular disease
- transcription factor
- pi k akt
- mesenchymal stem cells
- ultrasound guided
- immune response
- binding protein
- cell therapy
- bone marrow
- dna binding
- tissue engineering
- structural basis
- tandem mass spectrometry